Intravitreal bevacizumab monotherapy for treatment-naive polypoidal choroidal vasculopathy

Indian J Ophthalmol. 2014 Jan;62(1):97. doi: 10.4103/0301-4738.126197.
No abstract available

Publication types

  • Letter

MeSH terms

  • Angiogenesis Inhibitors / administration & dosage
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Bevacizumab
  • Choroid Diseases / drug therapy*
  • Choroid Diseases / physiopathology
  • Humans
  • Intravitreal Injections
  • Treatment Outcome
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Visual Acuity

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • Vascular Endothelial Growth Factor A
  • Bevacizumab